{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:33:16Z","timestamp":1783636396643,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-024-04419-4","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T06:23:12Z","timestamp":1734934992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Incidence and risk factors of heart failure with preserved ejection fraction in elderly patients with hypertension"],"prefix":"10.1186","volume":"24","author":[{"given":"Min","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"issue":"11","key":"4419_CR1","first-page":"513","volume":"75","author":"SP Sathyanarayanan","year":"2022","unstructured":"Sathyanarayanan SP, Oberoi M, Saad Shaukat MH, Stys T, Stys A. Heart Failure with Preserved Ejection Fraction: Concise Review. South Dak medicine: J South Dak State Med Association. 2022;75(11):513\u20137.","journal-title":"South Dak medicine: J South Dak State Med Association"},{"issue":"2","key":"4419_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/clc.23321","volume":"43","author":"B Upadhya","year":"2020","unstructured":"Upadhya B, Kitzman DW. Heart failure with preserved ejection fraction: New approaches to diagnosis and management. Clin Cardiol. 2020;43(2):145\u201355.","journal-title":"Clin Cardiol"},{"issue":"1","key":"4419_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/ejhf.1029","volume":"20","author":"TM Gorter","year":"2018","unstructured":"Gorter TM, van Veldhuisen DJ, Bauersachs J, Borlaug BA, Celutkiene J, Coats AJS, et al. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018;20(1):16\u201337.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"4419_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s00059-022-05119-5","volume":"47","author":"J Wintrich","year":"2022","unstructured":"Wintrich J, Abdin A, B\u00f6hm M. Management strategies in heart failure with preserved ejection fraction. Herz. 2022;47(4):332\u20139.","journal-title":"Herz"},{"issue":"10","key":"4419_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","volume":"14","author":"SM Dunlay","year":"2017","unstructured":"Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat reviews Cardiol. 2017;14(10):591\u2013602.","journal-title":"Nat reviews Cardiol"},{"issue":"9","key":"4419_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41569-020-0363-2","volume":"17","author":"BA Borlaug","year":"2020","unstructured":"Borlaug BA. Evaluation and management of heart failure with preserved ejection fraction. Nat reviews Cardiol. 2020;17(9):559\u201373.","journal-title":"Nat reviews Cardiol"},{"issue":"6","key":"4419_CR7","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1053\/j.jvca.2020.07.016","volume":"35","author":"PS Pagel","year":"2021","unstructured":"Pagel PS, Tawil JN, Boettcher BT, Izquierdo DA, Lazicki TJ, Crystal GJ, et al. Heart Failure With Preserved Ejection Fraction: A Comprehensive Review and Update of Diagnosis, Pathophysiology, Treatment, and Perioperative Implications. J Cardiothorac Vasc Anesth. 2021;35(6):1839\u201359.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"4","key":"4419_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00059-022-05123-9","volume":"47","author":"A Deichl","year":"2022","unstructured":"Deichl A, Wachter R, Edelmann F. Comorbidities in heart failure with preserved ejection fraction. Herz. 2022;47(4):301\u20137.","journal-title":"Herz"},{"issue":"4","key":"4419_CR9","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s10557-021-07306-8","volume":"37","author":"P Vaz-Salvador","year":"2023","unstructured":"Vaz-Salvador P, Ad\u00e3o R, Vasconcelos I, Leite-Moreira AF, Br\u00e1s-Silva C. Heart Failure with Preserved Ejection Fraction: a Pharmacotherapeutic Update. Cardiovasc Drugs Ther. 2023;37(4):815\u201332.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"9","key":"4419_CR10","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.cardfail.2021.04.013","volume":"27","author":"MF Cosiano","year":"2021","unstructured":"Cosiano MF, Tobin R, Mentz RJ, Greene SJ. Physical Functioning in Heart Failure With Preserved Ejection Fraction. J Card Fail. 2021;27(9):1002\u201316.","journal-title":"J Card Fail"},{"issue":"19","key":"4419_CR11","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1056\/NEJMcp1511175","volume":"375","author":"MM Redfield","year":"2016","unstructured":"Redfield MM. Heart Failure with Preserved Ejection Fraction. N Engl J Med. 2016;375(19):1868\u201377.","journal-title":"N Engl J Med"},{"key":"4419_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-med-042220-022745","volume":"73","author":"K Omote","year":"2022","unstructured":"Omote K, Verbrugge FH, Borlaug BA. Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies. Annu Rev Med. 2022;73:321\u201337.","journal-title":"Annu Rev Med"},{"issue":"1","key":"4419_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s40537-021-00537-4","volume":"8","author":"T Ashine","year":"2021","unstructured":"Ashine T, Muleta G, Tadesse K. Assessing survival time of heart failure patients: using Bayesian approach[J]. J Big Data. 2021;8(1):156.","journal-title":"J Big Data"},{"issue":"3","key":"4419_CR14","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3390\/stats7030063","volume":"7","author":"T Ashine","year":"2024","unstructured":"Ashine T, Tadesse Likassa H, Chen DG. Estimating Time-to-Death and Determining Risk Predictors for Heart Failure Patients: Bayesian AFT Shared Frailty Models with the INLA Method[J]. Stats. 2024;7(3):1066\u201383.","journal-title":"Stats"},{"issue":"10","key":"4419_CR15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jama.2023.2020","volume":"329","author":"MM Redfield","year":"2023","unstructured":"Redfield MM, Borlaug BA. Heart Failure With Preserved Ejection Fraction: A Review. JAMA. 2023;329(10):827\u201338.","journal-title":"JAMA"},{"issue":"18","key":"4419_CR16","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","volume":"81","author":"BA Borlaug","year":"2023","unstructured":"Borlaug BA, Sharma K, Shah SJ, Ho JE. Heart Failure With Preserved Ejection Fraction: JACC Scientific Statement. J Am Coll Cardiol. 2023;81(18):1810\u201334.","journal-title":"J Am Coll Cardiol"},{"key":"4419_CR17","unstructured":"2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. Journal of geriatric cardiology: JGC. 2019;16(3):182\u2013241."},{"issue":"3","key":"4419_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.hfc.2021.02.007","volume":"17","author":"CY Shim","year":"2021","unstructured":"Shim CY. Stress Testing in Heart Failure with Preserved Ejection Fraction. Heart Fail Clin. 2021;17(3):435\u201345.","journal-title":"Heart Fail Clin"},{"issue":"4","key":"4419_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.hfc.2022.03.010","volume":"18","author":"PS Jhund","year":"2022","unstructured":"Jhund PS. SGLT2 Inhibitors and Heart Failure with Preserved Ejection Fraction. Heart Fail Clin. 2022;18(4):579\u201386.","journal-title":"Heart Fail Clin"},{"issue":"20","key":"4419_CR20","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","volume":"70","author":"KS Shah","year":"2017","unstructured":"Shah KS, Xu H, Matsouaka RA, Bhatt DL, Heidenreich PA, Hernandez AF, et al. Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. J Am Coll Cardiol. 2017;70(20):2476\u201386.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"4419_CR21","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jchf.2023.03.011","volume":"11","author":"AS Desai","year":"2023","unstructured":"Desai AS, Lam CSP, McMurray JJV, Redfield MM. How to Manage Heart Failure With Preserved Ejection Fraction: Practical Guidance for Clinicians. JACC Heart Fail. 2023;11(6):619\u201336.","journal-title":"JACC Heart Fail"},{"issue":"10431","key":"4419_CR22","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0140-6736(23)02756-3","volume":"403","author":"P Campbell","year":"2024","unstructured":"Campbell P, Rutten FH, Lee MM, Hawkins NM, Petrie MC. Heart failure with preserved ejection fraction: everything the clinician needs to know. Lancet (London England). 2024;403(10431):1083\u201392.","journal-title":"Lancet (London England)"},{"issue":"9","key":"4419_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrcardio.2014.83","volume":"11","author":"BA Borlaug","year":"2014","unstructured":"Borlaug BA. The pathophysiology of heart failure with preserved ejection fraction. Nat reviews Cardiol. 2014;11(9):507\u201315.","journal-title":"Nat reviews Cardiol"},{"issue":"18","key":"4419_CR24","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895\u20131032.","journal-title":"Circulation"},{"issue":"4","key":"4419_CR25","doi-asserted-by":"publisher","first-page":"e007840","DOI":"10.1161\/CIRCHEARTFAILURE.120.007840","volume":"14","author":"M Guazzi","year":"2021","unstructured":"Guazzi M, Naeije R. Right Heart Phenotype in Heart Failure With Preserved Ejection Fraction. Circulation Heart Fail. 2021;14(4):e007840.","journal-title":"Circulation Heart Fail"},{"issue":"10","key":"4419_CR26","doi-asserted-by":"publisher","first-page":"e010080","DOI":"10.1161\/CIRCHEARTFAILURE.122.010080","volume":"15","author":"A Peikert","year":"2022","unstructured":"Peikert A, Martinez FA, Vaduganathan M, Claggett BL, Kulac IJ, Desai AS, et al. Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER Trial. Circulation Heart Fail. 2022;15(10):e010080.","journal-title":"Circulation Heart Fail"},{"issue":"11","key":"4419_CR27","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.119.313572","volume":"124","author":"MA Pfeffer","year":"2019","unstructured":"Pfeffer MA, Shah AM, Borlaug BA. Heart Failure With Preserved Ejection Fraction In Perspective. Circul Res. 2019;124(11):1598\u2013617.","journal-title":"Circul Res"},{"issue":"4","key":"4419_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1161\/CIRCULATIONAHA.122.057444","volume":"146","author":"YNV Reddy","year":"2022","unstructured":"Reddy YNV, Borlaug BA, Gersh BJ. Management of Atrial Fibrillation Across the Spectrum of Heart Failure With Preserved and Reduced Ejection Fraction. Circulation. 2022;146(4):339\u201357.","journal-title":"Circulation"},{"issue":"12","key":"4419_CR29","doi-asserted-by":"publisher","first-page":"e021120","DOI":"10.1161\/JAHA.121.021120","volume":"10","author":"R Samson","year":"2021","unstructured":"Samson R, Le Jemtel TH. Therapeutic Stalemate in Heart Failure With Preserved Ejection Fraction. J Am Heart Association. 2021;10(12):e021120.","journal-title":"J Am Heart Association"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04419-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-04419-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04419-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T19:02:08Z","timestamp":1734980528000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-04419-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4419"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-04419-4","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Institutional Review Board and Ethics Committee of Chengdu Seventh People\u2019s Hospital. Informed consent was waived for this retrospective study because it solely utilized de-identified patient data, which had no potential harm or impact on patient care. The Institutional Review Board and Ethics Committee of Chengdu Seventh People\u2019s Hospital granted approval for this waiver in accordance with the regulatory and ethical guidelines governing retrospective research studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"742"}}